signals

HPAI reaches 203 million birds lost in US — European dairy cattle spillover signals new risk vector

The 2022–2026 US HPAI outbreak has now cost 203 million birds across 1,000+ commercial flocks. An ECDC/EFSA overview flags a potential first H5N1 spillover into European dairy cattle in the Netherlands — carrying major implications for EU dairy export certification.

By Editor, GFO · · 2 min read
HPAI reaches 203 million birds lost in US — European dairy cattle spillover signals new risk vector

The 2022–2026 US HPAI outbreak has resulted in the loss of more than 203 million birds across over 1,000 commercial flocks according to USDA APHIS records, making it the largest and most economically damaging poultry disease event in American history. Turkey operations account for more than half of affected flocks.

Key data points

  • Between 29 November 2025 and 27 February 2026, 2,514 HPAI A(H5) detections were reported in domestic and wild birds across 32 countries in Europe. Waterfowl species were affected to a greater extent than in previous years, with more than 90% of poultry detections due to primary introduction from wild birds. (ECDC/EFSA Avian Influenza Overview, March 2026)
  • The ECDC overview flagged a potential spillover event from wild birds to dairy cattle in the Netherlands — the first such suggestion in Europe — a development carrying significant implications given the prior pattern of US dairy cattle transmission. (ECDC/EFSA Avian Influenza Overview, March 2026)
  • Human infections remain rare. No instance of human-to-human transmission has been documented. The risk for the general EU/EEA public is assessed as low; low-to-moderate for those occupationally exposed to infected animals. (ECDC/EFSA Avian Influenza Overview, March 2026)

Implication

The potential H5N1 spillover into European dairy cattle — if confirmed — would mark a significant geographic extension of a risk vector that caused substantial production disruption in US dairy in 2024–25. European dairy exporters, including Ireland's export-oriented sector, should treat this as a material biosecurity alert. Any confirmed dairy cattle transmission in an EU country will trigger trade access uncertainty in key markets, particularly China and Southeast Asia, where import health certification is closely tied to freedom-from-disease status.

Sources: ECDC/EFSA Avian Influenza Overview, March 2026; USDA APHIS, 2026; PoultryHatch.com, April 2026

Decision Pathway GFO · Business Intelligence Layer
→  How does this move through the system?

H5N1 spillover from poultry to European dairy cattle mirrors 2024-25 US transmission pattern → cross-species adaptation increases endemic establishment risk in EU livestock → Irish/EU dairy exports face certification suspension from disease-free status loss → China/Southeast Asia market access disruption threatens €5B+ annual trade flows.

⚡  Where does it hit commercially?
  • EU Dairy Exporters: Netherlands confirmation would trigger immediate health certification reviews for all EU dairy products destined for China and Southeast Asia. Irish dairy sector (€6.8B exports, 40% to Asia-Pacific) faces potential market access suspension within 60-90 days of confirmed cattle-to-cattle transmission.
  • US Poultry Integrators: 203M bird losses have removed approximately 15% of US layer capacity, driving wholesale egg prices to record levels. Cal-Maine, Tyson, and Perdue face $2-3B combined replacement costs while turkey processors enter critical Thanksgiving production window with depleted breeding stock.
  • Global Feed & Genetics Suppliers: Reduced poultry placements cut corn/soy demand by estimated 8-12M metric tons annually. Conversely, breeding stock companies (Aviagen, Cobb-Vantress) face 18-24 month order backlogs for replacement genetics as US and EU rebuild flocks simultaneously.
◈  Who wins and who loses?
  • Losers: US egg producers face margin compression despite high prices as biosecurity costs surge 300-400%. EU dairy cooperatives (FrieslandCampina, Glanbia, Kerry Group) risk losing hard-won China market share built over decade. Southeast Asian poultry importers face 25-40% protein cost inflation as Thai/Brazilian alternatives prove insufficient to cover US/EU supply gaps.
  • Winners: Brazilian and Australian dairy exporters positioned to capture diverted Asian demand if EU certification lapses. Veterinary pharmaceutical companies (Zoetis, Boehringer Ingelheim) see accelerated demand for surveillance diagnostics and emergency vaccine stockpiles. Plant-based egg alternatives (JUST Egg, Eat Just) gain retail velocity as conventional egg prices exceed $5/dozen threshold.
signals signal-type-biosecurity

Related signals